Bioceres Crop Solutions Corp.BIOXEarnings & Financial Report
Nasdaq
NextMar 31, 2026
BIOX Q1 2026 Key Financial Metrics
Revenue
$77.6M
Gross Profit
$36.3M
Operating Profit
$7.2M
Net Profit
$-7.4M
Gross Margin
46.8%
Operating Margin
9.3%
Net Margin
-9.6%
YoY Growth
-16.8%
EPS
$-0.12
Financial Flow
Bioceres Crop Solutions Corp. Q1 2026 Financial Summary
Bioceres Crop Solutions Corp. reported revenue of $77.6M for Q1 2026, with a net profit of $-7.4M (-9.6% margin). Cost of goods sold was $41.3M, operating expenses totaled $29.1M.
Key Financial Metrics
| Total Revenue | $77.6M |
|---|---|
| Net Profit | $-7.4M |
| Gross Margin | 46.8% |
| Operating Margin | 9.3% |
| Report Period | Q1 2026 |
Income Statement
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $92.5M | $116.6M | $140.2M | $84.0M | $93.3M | $106.7M | $60.6M | $77.6M |
| YoY Growth | N/A | -8.4% | 50.9% | -9.2% | -20.0% | -23.9% | -27.9% | -16.8% |
Balance Sheet
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $846.8M | $819.7M | $819.5M | $836.1M | $827.3M | $835.2M | $798.2M | $734.9M |
| Liabilities | $512.5M | $487.1M | $484.3M | $487.6M | $481.2M | $488.9M | $453.2M | $446.5M |
| Equity | $334.3M | $332.6M | $335.3M | $348.5M | $346.0M | $346.3M | $345.0M | $288.3M |
Cash Flow
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $2.2M | $14.7M | $21.1M | $-17.4M | $5.2M | $-5.4M | $23.3M | $14.4M |